Electronic health records, the digital files from clinic visits, hospital stays, and test results, help researchers study dementia care in 2026. Family caregivers can ask clear questions about purpose, time, risks, privacy, sharing, and doctor updates before they agree.
Researchers now reuse these files to trace long disease paths and spot early memory signals in primary care. The same reuse can affect treatment choices, privacy, and family roles. The questions below help you check fit for your family.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What can health records show about dementia?
- What will joining ask of you and your person?
- How will shared record data be guarded?
- How do you keep access to the chart?
- What if the chart misses the caregiver?
What can health records show about dementia?
Columbia University's M3AD platform joined records from nearly 10 million patients in New York, Chicago and Miami. It included about 60,000 people with Alzheimer's and related dementias. The team studied decades-long pathways and risk prediction, according to the Columbia Mailman School of Public Health study reported March 2026 March 2026 platform report. A Regenstrief Institute-Indiana University team built a primary-care tool that needs no extra visit time.
It pairs Quick Dementia Rating System answers, short family ratings of memory and daily function, with language software that reads visit notes. The software flags memory, vascular and other dementia-linked signals, according to Genetic Engineering and Biotechnology News in November 2025. A 2026 Frontiers in Psychiatry cohort study reused records to compare hard-to-treat depression in Alzheimer's, vascular dementia and dementia with Lewy bodies. These projects show records can reveal patterns no single visit shows. Ask whether a study uses past charts only or adds new tests and visits.
What will joining ask of you and your person?
Alzheimer's Association, National Institute on Aging and federal research-participation guidance urge families to ask the study team key questions before signing informed consent. Those questions cover purpose, risks and benefits, visits and time, current treatments, doctor updates and result sharing, according to the Alzheimer's Association Alzheimer's Association guidance on talking with your doctor about trials. Bring this list to the consent talk and write down answers.
Use the answers to judge time, travel and backup care. Ask who must sign if memory loss limits consent and whether you can leave later. Ask what happens to care if you leave.
- What is the purpose and possible benefit for our family?
- What are the risks and discomforts?
- How many visits, how long, where, and can any part happen from home?
- Do regular medicines and care continue during the study?
- How will you update our regular doctor?
How will shared record data be guarded?
Federally funded studies follow the National Institutes of Health Data Management and Sharing policy, which sets minimum sharing expectations. The National Institute on Aging toolkit points Alzheimer's and aging researchers to repositories such as the AD Knowledge Portal. Ask what record pieces will be shared, where they will go, for how long, and with what safeguards.
The National Institutes of Health next Alzheimer's precision-medicine partnership expands deep molecular study in diverse groups. It requires open sharing of data, methods and results so teams worldwide can build targeted treatments. Ask whether your family's records feed that open pool and what choices you have.
How do you keep access to the chart?
Federal information-blocking rules require groups using certified health technology to give patients secure electronic access at no cost. Federal officials have moved to fine blocking, with up to $1 million per violation for developers, according to the American Medical Association American Medical Association summary of blocking enforcement.
Ask for proxy portal access if you help manage care. Ask how to get copies, fix errors, and see who viewed the file.
What if the chart misses the caregiver?
Routine records often leave out caregiver names and roles. A July 2025 Annals of Family Medicine analysis of Canada's sentinel network found caregiver-patient pairs poorly captured, according to McKnight's McKnight's report on the caregiver-information analysis.
De-identified reuse, records stripped of names and direct tags, may move ahead without individual permission. Ask whether the study uses identifiable or de-identified files and which review board, called an IRB, oversees it. Ask to add your name, role and contact to the chart.
You Might Also Like
- UAS-CLEAR Dementia Care Research Data Priorities in 2026: Questions Family Caregivers Can Ask About the Research
- NHATS and NSOC Dementia Care Data Priorities in 2026: Questions Family Caregivers Can Ask About the Research
- The 2026 NIA Workshop on Comprehensive Dementia Care Models: Care-Planning Implications for Family Caregivers
